Citations (29)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Shi-Ping Yang, Ping Zhou, Chen-Lu Lian, Zhen-Yu He & San-Gang Wu. (2022) The Predictive Effect of the 8th AJCC Pathological Prognostic Staging on the Benefit of Postmastectomy Radiotherapy in N2/N3 Breast Cancer. Breast Cancer: Targets and Therapy 14, pages 133-144.
Read now
Read now
Articles from other publishers (28)
Yishuai Liu, Haifeng Han, Hong Wei, Xinlong Wang, Zhaotang Luan & Kun Jiang. (2024) Predictive Modelling of Overall Survival in Adult Patients with Primary
Diffuse Large B-cell Lymphoma of the Breast Using the Surveillance,
Epidemiology, and End Results (SEER) Database. Recent Patents on Anti-Cancer Drug Discovery 19:3, pages 373-382.
Crossref
Crossref
Kai CC Johnson, Michael Grimm, Jasmine Sukumar, Patrick M. Schnell, Ko Un Park, Daniel G. Stover, Sachin R. Jhawar, Margaret Gatti-Mays, Robert Wesolowski, Nicole Williams, Sagar Sardesai, Ashley Pariser, Preeti Sudheendra, Gary Tozbikian, Bhuvaneswari Ramaswamy, Dureti Doto & Mathew A. Cherian. (2023) Survival outcomes seen with neoadjuvant chemotherapy in the management of locally advanced inflammatory breast cancer (IBC) versus matched controls. The Breast 72, pages 103591.
Crossref
Crossref
Kemba A. Peters, Patrick O. Roberts, Derria A. Cornwall, Derek I. Mitchell & Rory K. Thompson. (2022) Clinicopathological Factors Affecting Breast Cancer Survival in Jamaican Women: A Retrospective Review. Journal of Racial and Ethnic Health Disparities 10:2, pages 844-858.
Crossref
Crossref
Ranjitha Guttapadu, Teesta Katte, Deepak Sayeeram, Saloni Bhatia, Anika Rachel Abraham, Kiran Rajeev, Anish Raju R. Amara, Sharadhi Siri, Kavitha Bommana, Avinash Arvind Rasalkar, Rajyalakshmi Malempati, Mohammed S. Mustak, Prathibha Narayanan & S. Divijendra Natha Reddy. (2023) Identification of novel biomarkers for lung squamous cell carcinoma. 3 Biotech 13:2.
Crossref
Crossref
Ruiyang Wu, Jing Luo, Hangyu Wan, Haiyan Zhang, Yewei Yuan, Huihua Hu, Jinyan Feng, Jing Wen, Yan Wang, Junyan Li, Qi Liang, Fengjiao Gan & Gang Zhang. (2023) Evaluation of machine learning algorithms for the prognosis of breast cancer from the Surveillance, Epidemiology, and End Results database. PLOS ONE 18:1, pages e0280340.
Crossref
Crossref
Yudong Zhou, Shengyu Pu, Siyuan Jiang, Danni Li, Shouyu Li, Yang Liu, Yu Ren & Na Hao. (2022) The prognostic significance of further axillary dissection for sentinel lymph node micrometastases in female breast cancer: A competing risk analysis using the SEER database. Frontiers in Oncology 12.
Crossref
Crossref
Jing Ning, Tao Ge, Shuncang Zhu, Yingli Han, Suhong Ruan, Yuchen Ma & Rentao Liu. (2022) The role of surgery in older patients with T1-2N0M0 small cell lung cancer: A propensity score matching analysis. Frontiers in Oncology 12.
Crossref
Crossref
Kathryn Shum, Abdulkadir Hussein & Caroline Hamm. (2022) Are we overtreating stage I triple-negative breast cancer in Ontario? A population-based retrospective epidemiological analysis using the ICES database. Medical Oncology 39:12.
Crossref
Crossref
Xian Ye, Yang Liu, Junling Yang, Yan Wang, Xiaohong Cui, Hongjun Xie, Lining Song, Zihan Ding, Ronghua Zhai, Yi Han, Lei Yang & Haijian Zhang. (2022) Do older patients with stage IB non-small-cell lung cancer obtain survival benefits from surgery? A propensity score matching study using SEER data. European Journal of Surgical Oncology 48:9, pages 1954-1963.
Crossref
Crossref
Jiang Zhong, XingShu Liao, Shuang Peng, Junyi Cao, Yue Liu, Chunyang Liu, Ju Qiu, Xiaoyan Guan, Yang Zhang, Xiaozhu Liu & Shengxian Peng. (2022) A Visualized Dynamic Prediction Model for Overall Survival in Elderly Patients With Pancreatic Cancer for Smart Medical Services. Frontiers in Public Health 10.
Crossref
Crossref
Guan-Qiao Li, Yang Yu, Wen-Wen Zhang, Ping Zhou, Chen-Lu Lian, Zhen-Yu He & San-Gang Wu. (2022) Impact of AJCC prognostic staging on prognosis and postmastectomy radiotherapy decision-making in hormone receptor-positive and HER2-positive breast cancer. BJS Open 6:2.
Crossref
Crossref
Min Yang, Huan Liu, Qingli Dai, Ling Yao, Shun Zhang, Zhihong Wang, Jing Li & Qinghong Duan. (2022) Treatment Response Prediction Using Ultrasound-Based Pre-, Post-Early, and Delta Radiomics in Neoadjuvant Chemotherapy in Breast Cancer. Frontiers in Oncology 12.
Crossref
Crossref
Mary R. Nittala, Eswar K. Mundra, S. Packianathan, Divyang Mehta, Maria L. Smith, William C. Woods, Shawn McKinney, Barbara S. Craft & Srinivasan Vijayakumar. (2021) The Will Rogers phenomenon, breast cancer and race. BMC Cancer 21:1.
Crossref
Crossref
Soo Jung Lee, Jeeyeon Lee, Jin Hyang Jung, Ho Yong Park, Pyong-Gon Moon, Yee Soo Chae & Moon-Chang Baek. (2021) Exosomal Del-1 as a Potent Diagnostic Marker for Breast Cancer: Prospective Cohort Study. Clinical Breast Cancer 21:6, pages e748-e756.
Crossref
Crossref
Aysegul Aktas, Selda Oguz Aslayan, Meryem Gunay Gurleyik & Serkan Gungor. (2021) Correlations of Primary Tumor SUVmax and Axillary Lymph Node SUVmax with Molecular Subtypes of Invasive Breast Cancer. Indian Journal of Surgery 83:S2, pages 468-474.
Crossref
Crossref
ChangHyuk Kwon, Sangjin Park, Soohyun Ko & Jaegyoon Ahn. (2021) Increasing prediction accuracy of pathogenic staging by sample augmentation with a GAN. PLOS ONE 16:4, pages e0250458.
Crossref
Crossref
Rana Aldrees, Xiaoqing Gao, Kui Zhang, Gene P. Siegal & Shi Wei. (2021) Validation of the revised 8th AJCC breast cancer clinical prognostic staging system: analysis of 5321 cases from a single institution. Modern Pathology 34:2, pages 291-299.
Crossref
Crossref
Chen-Lu Lian, Hai-Yan Zhang, Jun Wang, Jian Lei, Li Hua, Yong-Xiong Chen & San-Gang Wu. (2021) Staging for Breast Cancer With Internal Mammary Lymph Nodes Metastasis: Utility of Incorporating Biologic Factors. Frontiers in Oncology 10.
Crossref
Crossref
Jian Shi, Chen-Lu Lian, Feng Chi, Ping Zhou, Jian Lei, Li Hua, Jun Wang, Zhen-Yu He & San-Gang Wu. (2020) Prognostic and Predictive Value of the American Joint Committee on Cancer Pathological Prognostic Staging System in Nodal Micrometastatic Breast Cancer. Frontiers in Oncology 10.
Crossref
Crossref
Jiehua He, Julia Y. Tsang, Xiaodan Xu, Jibin Li, Mei Li, Xue Chao, Yuanyuan Xu, Rongzhen Luo, Gary M. Tse & Peng Sun. (2020) AJCC 8th edition prognostic staging provides no better discriminatory ability in prognosis than anatomical staging in triple negative breast cancer. BMC Cancer 20:1.
Crossref
Crossref
Eriko Tokunaga, Hideki Ijichi, Wakako Tajiri, Takanobu Masuda, Katsumi Takizawa, Hiroki Ueo, Chinami Koga, Junko Tanaka, Yoshiaki Nakamura, Shinji Ohno, Kenichi Taguchi & Masahiro Okamoto. (2020) The comparison of the anatomic stage and pathological prognostic stage according to the AJCC 8th edition for the prognosis in Japanese breast cancer patients: data from a single institution. Breast Cancer 27:6, pages 1137-1146.
Crossref
Crossref
Joana Reis, Jonas Christoffer Lindstrøm, Joao Boavida, Kjell-Inge Gjesdal, Daehoon Park, Nazli Bahrami, Manouchehr Seyedzadeh, Woldegabriel A. Melles, Torill Sauer, Jürgen Geisler & Jonn Terje Geitung. (2020) Accuracy of breast MRI in patients receiving neoadjuvant endocrine therapy: comprehensive imaging analysis and correlation with clinical and pathological assessments. Breast Cancer Research and Treatment 184:2, pages 407-420.
Crossref
Crossref
Huimin Jin, Yuqian Feng, Kaibo Guo & Shanming Ruan. (2020) Prognostic Nomograms for Predicting Overall Survival and Cancer-Specific Survival of Patients With Early Onset Colon Adenocarcinoma. Frontiers in Oncology 10.
Crossref
Crossref
San-Gang Wu, Jian Shi, Wen-Wen Zhang, Jun Wang, Chen-Lu Lian, Jian Lei, Li Hua, Juan Zhou & Zhen-Yu He. (2020) Prognostic validation and treatment decision making of the 8th edition of the American Joint Committee on Cancer pathological staging system for elderly women with early-stage breast cancer. Aging 12:14, pages 15077-15090.
Crossref
Crossref
Juan Zhou, Jian Lei, Jun Wang, Chen-Lu Lian, Li Hua, Li-Chao Yang & San-Gang Wu. (2020) Validation of the 8th edition of the American Joint Committee on Cancer Pathological Prognostic Staging for young breast cancer patients. Aging 12:8, pages 7549-7560.
Crossref
Crossref
Min Shi, Biao Zhou & Shu-Ping Yang. (2020) Nomograms for predicting overall survival and cancer-specific survival in young patients with pancreatic cancer in the US based on the SEER database. PeerJ 8, pages e8958.
Crossref
Crossref
Maria Vittoria Dieci, Giancarlo Bisagni, Alba A. Brandes, Antonio Frassoldati, Luigi Cavanna, Francesco Giotta, Michele Aieta, Vittorio Gebbia, Antonino Musolino, Ornella Garrone, Michela Donadio, Anita Rimanti, Alessandra Beano, Claudio Zamagni, Hector Soto Parra, Federico Piacentini, Saverio Danese, Antonella Ferro, Katia Cagossi, Samanta Sarti, Anna Rita Gambaro, Sante Romito, Viviana Bazan, Laura Amaducci, Gabriella Moretti, Maria Pia Foschini, Sara Balduzzi, Roberto Vicini, Roberto D’Amico, Gaia Griguolo, Valentina Guarneri & Pier Franco Conte. (2019) Validation of the AJCC prognostic stage for HER2-positive breast cancer in the ShortHER trial. BMC Medicine 17:1.
Crossref
Crossref
Merisa L. Piper, Jasmine Wong, Kelly Fahrner-Scott, Cheryl Ewing, Michael Alvarado, Laura J. Esserman & Rita A. Mukhtar. (2019) Success rates of re-excision after positive margins for invasive lobular carcinoma of the breast. npj Breast Cancer 5:1.
Crossref
Crossref